PL369447A1 - Sposób wytwarzania związków insuliny - Google Patents
Sposób wytwarzania związków insulinyInfo
- Publication number
- PL369447A1 PL369447A1 PL02369447A PL36944702A PL369447A1 PL 369447 A1 PL369447 A1 PL 369447A1 PL 02369447 A PL02369447 A PL 02369447A PL 36944702 A PL36944702 A PL 36944702A PL 369447 A1 PL369447 A1 PL 369447A1
- Authority
- PL
- Poland
- Prior art keywords
- insulin compounds
- preparing insulin
- compounds
- insulin
- ester
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- -1 amino acid ester Chemical class 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 239000013067 intermediate product Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 230000007030 peptide scission Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101716 | 2001-11-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL369447A1 true PL369447A1 (pl) | 2005-04-18 |
| PL210437B1 PL210437B1 (pl) | 2012-01-31 |
Family
ID=8160841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL369447A PL210437B1 (pl) | 2001-11-19 | 2002-11-15 | Sposób wytwarzania związków insuliny |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1448786B1 (pl) |
| JP (1) | JP4404631B2 (pl) |
| KR (1) | KR100925381B1 (pl) |
| CN (1) | CN100424179C (pl) |
| AT (1) | ATE464390T1 (pl) |
| AU (1) | AU2002342597A1 (pl) |
| BR (1) | BR0213583A (pl) |
| CA (1) | CA2464616C (pl) |
| DE (1) | DE60236014D1 (pl) |
| ES (1) | ES2344448T3 (pl) |
| HU (1) | HU228934B1 (pl) |
| IL (2) | IL161358A0 (pl) |
| PL (1) | PL210437B1 (pl) |
| RU (1) | RU2376379C2 (pl) |
| WO (1) | WO2003044210A2 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006031962A1 (de) * | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Amidiertes Insulin Glargin |
| DE102006031955A1 (de) | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende |
| TW200902708A (en) * | 2007-04-23 | 2009-01-16 | Wyeth Corp | Methods of protein production using anti-senescence compounds |
| PT3228320T (pt) | 2008-10-17 | 2020-03-26 | Sanofi Aventis Deutschland | Combinação de uma insulina e de um agonista do glp-1 |
| KR101853606B1 (ko) | 2009-07-06 | 2018-05-03 | 사노피-아벤티스 도이칠란트 게엠베하 | 메티오닌을 함유하는 수성 인슐린 제제 |
| PL2464655T3 (pl) * | 2009-08-11 | 2017-08-31 | Biocon Limited | Procesy chromatograficzne |
| KR101337322B1 (ko) | 2009-11-13 | 2013-12-06 | 사노피-아벤티스 도이칠란트 게엠베하 | Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물 |
| DK2498802T3 (en) | 2009-11-13 | 2015-04-13 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine |
| ES2606554T3 (es) | 2010-08-30 | 2017-03-24 | Sanofi-Aventis Deutschland Gmbh | Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| PL2750699T3 (pl) | 2011-08-29 | 2015-12-31 | Sanofi Aventis Deutschland | Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2 |
| AR087744A1 (es) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa |
| CN102703552B (zh) * | 2012-05-15 | 2014-10-29 | 山东阿华生物药业有限公司 | 重组人胰岛素的制备方法及其产品 |
| CN102816819B (zh) * | 2012-08-13 | 2014-10-29 | 山东阿华生物药业有限公司 | 提高人胰岛素前体融合蛋白酶切转换成b30缺苏氨酸人胰岛素产率的方法 |
| CN103305581B (zh) * | 2013-07-04 | 2015-05-27 | 珠海联邦制药股份有限公司 | 一种重组人胰岛素的制备方法 |
| CN105849273B (zh) * | 2013-12-23 | 2020-01-14 | 拜康研究有限公司 | 人胰岛素甲酯的生产方法 |
| AU2015359376B2 (en) | 2014-12-12 | 2021-09-09 | Sanofi-Aventis Deutschland Gmbh | Insulin glargine/lixisenatide fixed ratio formulation |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| EP3341405A4 (en) * | 2015-09-24 | 2019-05-01 | Hanmi Pharm. Co., Ltd. | PROCESS FOR INSULIN PRODUCTION |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4343898A (en) | 1980-02-11 | 1982-08-10 | Novo Industri A/S | Process for preparing esters of human insulin |
| EP0088117B1 (en) | 1981-09-15 | 1986-09-24 | Nordisk Insulinlaboratorium | Process for preparing human insulin or b-30 esters thereof |
| DE3262052D1 (en) | 1981-08-10 | 1985-03-07 | Nordisk Insulinlab | Process for the enzymatic preparation of human insulin |
| DK149824C (da) | 1982-01-22 | 1987-03-16 | Carlsberg Biotechnology Ltd | Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyrer i insuliner |
| WO1983002772A1 (en) | 1982-02-08 | 1983-08-18 | Robin Ewart Offord | An improved method for preparing human insulin from non-human insulin |
| DK347086D0 (da) | 1986-07-21 | 1986-07-21 | Novo Industri As | Novel peptides |
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| IL84110A (en) * | 1986-10-14 | 1992-11-15 | Lilly Co Eli | Process for transforming a human insulin precursor to a human insulin |
| DE3880346T2 (de) | 1987-02-25 | 1993-07-29 | Novonordisk As | Insulinderivate. |
| SI0792290T1 (en) | 1993-09-17 | 2001-12-31 | Novo Nordisk As | Acylated insulin |
| US6011007A (en) | 1993-09-17 | 2000-01-04 | Novo Nordisk A/S | Acylated insulin |
| RU2141531C1 (ru) * | 1999-05-26 | 1999-11-20 | Российское акционерное общество открытого типа "Биопрепарат" | Способ получения рекомбинантного инсулина человека |
| CA2392844A1 (en) | 1999-12-29 | 2001-07-12 | Novo Nordisk A/S | Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| JP4773023B2 (ja) | 1999-12-29 | 2011-09-14 | ノボ ノルディスク アクティーゼルスカブ | インスリン前駆体及びインスリン前駆体類似体の製造方法 |
| CA2409347C (en) | 2000-04-14 | 2010-03-30 | Frank T. Robb | Enhanced protein thermostability and temperature resistance |
| WO2002079254A1 (en) | 2001-03-29 | 2002-10-10 | Janoff Edward N | Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae |
-
2002
- 2002-11-15 RU RU2004118503/13A patent/RU2376379C2/ru not_active IP Right Cessation
- 2002-11-15 EP EP02779247A patent/EP1448786B1/en not_active Expired - Lifetime
- 2002-11-15 CN CNB028229622A patent/CN100424179C/zh not_active Expired - Lifetime
- 2002-11-15 WO PCT/DK2002/000765 patent/WO2003044210A2/en not_active Ceased
- 2002-11-15 JP JP2003545831A patent/JP4404631B2/ja not_active Expired - Lifetime
- 2002-11-15 BR BR0213583-3A patent/BR0213583A/pt not_active Application Discontinuation
- 2002-11-15 PL PL369447A patent/PL210437B1/pl unknown
- 2002-11-15 IL IL16135802A patent/IL161358A0/xx unknown
- 2002-11-15 AU AU2002342597A patent/AU2002342597A1/en not_active Abandoned
- 2002-11-15 KR KR1020047007129A patent/KR100925381B1/ko not_active Expired - Fee Related
- 2002-11-15 AT AT02779247T patent/ATE464390T1/de not_active IP Right Cessation
- 2002-11-15 ES ES02779247T patent/ES2344448T3/es not_active Expired - Lifetime
- 2002-11-15 HU HU0500037A patent/HU228934B1/hu not_active IP Right Cessation
- 2002-11-15 CA CA2464616A patent/CA2464616C/en not_active Expired - Fee Related
- 2002-11-15 DE DE60236014T patent/DE60236014D1/de not_active Expired - Lifetime
-
2004
- 2004-04-14 IL IL161358A patent/IL161358A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002342597A8 (en) | 2003-06-10 |
| CN1589328A (zh) | 2005-03-02 |
| JP4404631B2 (ja) | 2010-01-27 |
| WO2003044210A2 (en) | 2003-05-30 |
| KR100925381B1 (ko) | 2009-11-09 |
| RU2376379C2 (ru) | 2009-12-20 |
| AU2002342597A1 (en) | 2003-06-10 |
| DE60236014D1 (de) | 2010-05-27 |
| EP1448786A2 (en) | 2004-08-25 |
| IL161358A (en) | 2011-05-31 |
| IL161358A0 (en) | 2004-09-27 |
| JP2005509687A (ja) | 2005-04-14 |
| PL210437B1 (pl) | 2012-01-31 |
| EP1448786B1 (en) | 2010-04-14 |
| KR20050044855A (ko) | 2005-05-13 |
| CN100424179C (zh) | 2008-10-08 |
| CA2464616A1 (en) | 2003-05-30 |
| HUP0500037A2 (hu) | 2005-03-29 |
| ES2344448T3 (es) | 2010-08-27 |
| BR0213583A (pt) | 2004-08-24 |
| CA2464616C (en) | 2012-07-24 |
| RU2004118503A (ru) | 2005-06-10 |
| ATE464390T1 (de) | 2010-04-15 |
| WO2003044210A3 (en) | 2004-03-25 |
| HUP0500037A3 (en) | 2010-01-28 |
| HU228934B1 (hu) | 2013-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002342597A8 (en) | Process for preparing insulin compounds | |
| EG23843A (en) | Modified pictet-spengler reaction and products prepared therefrom | |
| WO2002012530A3 (en) | 3-hydroxycarboxylic acid production and use in branched polymers | |
| EP1457487A4 (en) | PROCESS FOR PREPARING OPTICALLY ACTIVE CIS-PIPERIDINE DERIVATIVES | |
| AU2002215360A1 (en) | Production of alpha-hydroxy-carboxylic acids using a coupled enzyme system | |
| EP1316613A3 (en) | Method for producing optically active mandelic acid derivatives | |
| EP0896057A3 (en) | D-aminoacylase | |
| WO2003095670A3 (en) | Process for generating sequence-specific proteases by directed evolution and use thereof | |
| HUP9902963A2 (hu) | Eljárás aminoalkoholok és származékaik előállítására | |
| EP0927755A3 (en) | Haloaccloacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme | |
| AU2002310883A1 (en) | Process for the preparation of substituted carboxylic acid estersby enzymatic hydrolysis | |
| TW430641B (en) | Process for preparing optically active 2-amino-ω-oxoalkanoic acid derivatives | |
| HRP20030356A2 (en) | Process for enzymatic production of enantiomer-enriched -amino acids | |
| WO2003018523A1 (en) | Process for producing optically active halopropanediol derivative | |
| MXPA05008440A (es) | Procedimiento para la preparacion de aminoacidos aromaticos biciclicos e intermediarios de los mismos. | |
| IL179871A0 (en) | Process for the preparation of gabapentin | |
| NO20045513L (no) | Fremgangmate for fremstiling av konjugert linolsyre | |
| SI1109782T1 (sl) | Postopek za pripravo N-zascitenih azeditin-2-karboksilnih kislin (AzeOH) | |
| ATE202146T1 (de) | Verbesserte enzymatische kupplungsreaktion von n- geschützte l-asparaginsäure und phenylalaninmethylester | |
| AU2002356427A1 (en) | An improved process for the preparation of gabalactam | |
| EP1382683A3 (en) | Process for producing 3-hydroxycyclohexanone | |
| WO2003048161A8 (en) | A process for preparing 2,6-dichloropurine | |
| EP1568693A4 (en) | PROCESS FOR PRODUCING QUINOLINECARBALDEHYDE | |
| HK1050672A1 (zh) | 制备环己腈中间体和方法 | |
| WO2002095045A3 (fr) | Procede de preparation d'acides carboxyliques aliphatiques par hydrolyse enzymatique de composes nitriles aliphatiques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification |